Drug delivery strategies for cathepsin inhibitors in joint diseases.
about
Cathepsin K inhibitors for osteoporosis and potential off-target effectsSuppression of MMP activity in bovine cartilage explants cultures has little if any effect on the release of aggrecanase-derived aggrecan fragments.A potential therapeutic role for P2X7 receptor (P2X7R) antagonists in the treatment of inflammatory diseases.Modulating P2X7 Receptor Signaling during Rheumatoid Arthritis: New Therapeutic Approaches for BisphosphonatesTargeting the lysosome in cancer.Impaired turnover of autophagolysosomes in cathepsin L deficiency.
P2860
Drug delivery strategies for cathepsin inhibitors in joint diseases.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Drug delivery strategies for cathepsin inhibitors in joint diseases.
@ast
Drug delivery strategies for cathepsin inhibitors in joint diseases.
@en
type
label
Drug delivery strategies for cathepsin inhibitors in joint diseases.
@ast
Drug delivery strategies for cathepsin inhibitors in joint diseases.
@en
prefLabel
Drug delivery strategies for cathepsin inhibitors in joint diseases.
@ast
Drug delivery strategies for cathepsin inhibitors in joint diseases.
@en
P2860
P1476
Drug delivery strategies for cathepsin inhibitors in joint diseases.
@en
P2093
Dieter Brömme
P2860
P304
P356
10.1517/17425247.2.6.1015
P407
P577
2005-11-01T00:00:00Z